These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15629872)

  • 21. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
    Bould H; Wiles N; Potokar J; Cowen P; Nutt DJ; Peters TJ; Lewis G
    J Psychopharmacol; 2012 May; 26(5):663-9. PubMed ID: 22223618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
    Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
    World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination therapy with reboxetine for major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors].
    Rubio G; San L; López-Munoz F; García-García P; Alamo C
    Actas Esp Psiquiatr; 2003; 31(6):315-24. PubMed ID: 14639507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.
    Tranter R; Bell D; Gutting P; Harmer C; Healy D; Anderson IM
    J Affect Disord; 2009 Nov; 118(1-3):87-93. PubMed ID: 19250683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
    Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ
    Br J Psychiatry; 2011 Jun; 198(6):464-71. PubMed ID: 21263010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O; Hetzel G; Michael N; Rothermundt M; Arolt V; Erfurth A
    Neuropsychobiology; 2005; 51(2):67-71. PubMed ID: 15741746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.
    Kerestes R; Labuschagne I; Croft RJ; O'Neill BV; Bhagwagar Z; Phan KL; Nathan PJ
    Psychopharmacology (Berl); 2009 Mar; 202(4):621-34. PubMed ID: 18825371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J
    J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
    Murphy SE; Yiend J; Lester KJ; Cowen PJ; Harmer CJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):169-79. PubMed ID: 18752726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.
    Pjrek E; Konstantinidis A; Assem-Hilger E; Praschak-Rieder N; Willeit M; Kasper S; Winkler D
    J Psychiatr Res; 2009 May; 43(8):792-7. PubMed ID: 19230909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in serotonergic and noradrenergic regulation of human social behaviours.
    Tse WS; Bond AJ
    Psychopharmacology (Berl); 2002 Jan; 159(2):216-21. PubMed ID: 11862352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission.
    Oliva J; Leung S; Croft RJ; O'Neill BV; O'Kane J; Stout J; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2010 Jul; 25(5):423-7. PubMed ID: 20589921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment.
    Moeller O; Hetzel G; Rothermundt M; Michael N; Nyhuis PW; Suslow T; Arolt V; Erfurth A
    J Psychiatr Res; 2003; 37(3):261-2. PubMed ID: 12650745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.